Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen Bremer

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vitro Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vivo Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
The Journal of Investigative Dermatology|November 11, 2014
Transgenic mouse technology in skin biology: generation of knockin miceFrederik Tellkamp, Farida Benhadou, Jeroen Bremer, et al.
The Journal of Investigative Dermatology|January 25, 2024
The Autoimmune IgG Subclass Response Defines the IgG Deposition Pattern in Pemphigus Patient SkinHendri H Pas, Marije van der Molen, Laura van Nijen-Vos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapyOlivier Bornert, Tobias Kühl, Jeroen Bremer, et al.
Experimental Dermatology|February 23, 2024
Recommendations on single-cell RNA sequencing of skin xenografts in the study of genetic skin diseasesFranciscus C Vermeer, Marieke C Bolling, Nine V A M Knoers, et al.
JAAD Case Reports|December 25, 2025
Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumabMarjolein A J Hiel, Gilles F H Diercks, Maria C Bolling, et al.
Molecular Therapy. Nucleic Acids|July 1, 2026
Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapiesCisse Vermeer, Rindert R Venema, Erwin Birnie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2022
Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical casesFarhat Zaheri, Hendri H Pas, Jeroen Bremer, et al.
Acta Dermato-Venereologica|May 4, 2016
In-frame Exon Skipping in KRT5 due to Novel Intronic Deletion Causes Epidermolysis Bullosa Simplex, Generalized SevereKatarzyna B Gostyńska, Jeroen Bremer, Krista K van Dijk-Bos, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vitro Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
In Vivo Models for the Evaluation of Antisense Oligonucleotides in SkinJeroen Bremer, Peter C van den Akker
The Journal of Investigative Dermatology|November 11, 2014
Transgenic mouse technology in skin biology: generation of knockin miceFrederik Tellkamp, Farida Benhadou, Jeroen Bremer, et al.
The Journal of Investigative Dermatology|January 25, 2024
The Autoimmune IgG Subclass Response Defines the IgG Deposition Pattern in Pemphigus Patient SkinHendri H Pas, Marije van der Molen, Laura van Nijen-Vos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapyOlivier Bornert, Tobias Kühl, Jeroen Bremer, et al.
Experimental Dermatology|February 23, 2024
Recommendations on single-cell RNA sequencing of skin xenografts in the study of genetic skin diseasesFranciscus C Vermeer, Marieke C Bolling, Nine V A M Knoers, et al.
JAAD Case Reports|December 25, 2025
Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumabMarjolein A J Hiel, Gilles F H Diercks, Maria C Bolling, et al.
Molecular Therapy. Nucleic Acids|July 1, 2026
Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapiesCisse Vermeer, Rindert R Venema, Erwin Birnie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2022
Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical casesFarhat Zaheri, Hendri H Pas, Jeroen Bremer, et al.
Acta Dermato-Venereologica|May 4, 2016
In-frame Exon Skipping in KRT5 due to Novel Intronic Deletion Causes Epidermolysis Bullosa Simplex, Generalized SevereKatarzyna B Gostyńska, Jeroen Bremer, Krista K van Dijk-Bos, et al.
Pageof 3